Premium
Mycobacterium tuberculosis responsible for cutaneous disease after percutaneal inoculation of solutions: a case report
Author(s) -
Lilia Maria,
Olano Alejandro Muñoz,
Klinger Julio César
Publication year - 2003
Publication title -
international journal of dermatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.677
H-Index - 93
eISSN - 1365-4632
pISSN - 0011-9059
DOI - 10.1046/j.1365-4362.2003.01723_3.x
Subject(s) - medicine , tuberculosis , cutaneous tuberculosis , mycobacterium tuberculosis , incidence (geometry) , dermatology , public health , disease , surgery , immunology , pediatrics , pathology , physics , optics
Tuberculosis continues to be a public health problem, especially in developing countries. It is responsible for 3 million deaths annually. 1 Cutaneous infection is distributed worldwide, with an increased incidence in temple environments. 2 In the USA, cutaneous tuberculosis comprises 0.14% of reported tuberculosis cases. 3 Here we report a case of cutaneous tuberculosis in a woman undergoing neural therapy. The therapy included periumbilical injections of procainamide and a substance called ‘machura’, which formed part of an “antihomotoxic” homeopathic treatment whose composition is unknown.